VAERS reports by lot

Pfizer COVID-19 lot HG4664: VAERS reports

63 VAERS reports list lot HG4664 as a Pfizer COVID-19 vaccine, received between 2023-10-06 and 2024-09-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
11%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2921%
Neurological2820%
General / Systemic (non-local)2518%
Gastrointestinal1410%
Cardiac / Cardiovascular107%
Musculoskeletal64%
Psychiatric / Neuropsychiatric64%
Allergic / Anaphylactic54%
Respiratory54%
Dermatological (non-injection-site)54%
Thrombotic / Hematological32%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California20
Virginia7
Washington4
Illinois3
Arizona3
Maryland3
Minnesota3
Pennsylvania3
New Hampshire2
Ohio1
Oregon1
Colorado1

Reports by month received

2023-1019
2023-1110
2023-129
2024-019
2024-021
2024-033
2024-041
2024-067
2024-071
2024-081
2024-092

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.